Chiron Real Estate Inc. XRN

Real estate SIC 6798 - Real Estate Investment Trusts NAICS Real Estate and Rental and Leasing › Real Estate › Lessors of Real Estate derived NYSE

Chiron Real Estate Inc. (the "Company," "us," "we," or "our") is a Maryland corporation and internally managed REIT that primarily acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company's common stock is listed on the New York Stock Exchange. On February 23, 2026, the Company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc.

We elected to be taxed as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2016. We hold our facilities and conduct our operations through a Delaware limited partnership subsidiary, Chiron Real Estate LP (the "Operating Partnership"). Our wholly owned subsidiary, Chiron Real Estate GP LLC, is the sole general partner of our Operating Partnership and, as of December 31, 2025, we owned 92.0% of the outstanding common operating partnership units ("OP Units") of our Operating Partnership, with an aggregate of 8.0% of the Operating Partnership owned by holders of long-term incentive plan units ("LTIP Units") and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units.

Last close 30.00 2026-10-23
Market cap $397.1M 2026-06-30 share count
52-week range 28.63 - 38.65

Valuation FY2025 figures against the last close

P/S755.0x
P/E—
P/FCF5.4x
EV/EBITDA—
Dividend yield1.5%
Diluted EPS-0.91

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $526.0K$370.0K$115.0K$116.0K$132.0K$212.0K$211.0K$54.0K$121.0K$131.0K
SG&A $20.0M$21.1M$16.9M$16.5M$16.5M$11.9M$6.5M$5.5M$5.5M$4.2M
Total operating expenses ——$134.0M$124.0M$98.7M$96.2M$61.1M$46.3M$30.4M$14.6M
Interest expense $31.8M$28.7M$30.9M$25.2M$19.7M$18.7M$17.5M$15.0M$7.4M$4.1M
Net income -$6.9M$6.7M$21.7M$20.0M$18.3M-$2.5M$9.6M$14.6M-$87.0K-$6.4M
EPS, basic -0.910.061.130.200.19-0.170.10———
EPS, diluted -0.910.061.130.200.19-0.170.100.35-0.09-0.68
Shares, diluted (wtd. avg.) 13.4M13.2M13.1M65.5M60.6M46.3M33.9M———

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $9.1M$6.8M$6.7M$14.5M$12.8M$10.8M$7.2M$4.8M$7.1M$20.6M
Goodwill $5.9M$5.9M$5.9M$5.9M$5.9M$5.9M$0———
Other intangibles $46.0M$53.7M$65.5M$91.2M$87.7M$73.3M$59.1M$36.3M$29.3M$7.1M
Total assets $1.24B$1.26B$1.27B$1.39B$1.26B$1.10B$884.9M$636.1M$471.8M$227.3M
Long-term debt $1.2M$14.4M————————
Total liabilities $712.4M$700.6M$661.9M$744.2M$625.9M$643.1M$424.6M$336.3M$212.8M$72.3M
Retained earnings -$350.0M-$293.7M-$239.0M-$198.7M-$157.0M-$116.8M-$71.4M-$45.0M-$34.4M—
Total equity $509.8M$534.1M$605.8M$649.1M$637.6M$457.8M$460.4M$299.8M$259.0M$155.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $73.6M$70.0M$68.4M$76.5M$69.0M$34.5M$36.4M$24.8M$12.6M-$2.2M
Depreciation and amortisation $44.0M$40.4M$41.3M$40.0M$33.8M$26.7M$19.1M$13.6M$7.9M$2.3M
Stock-based compensation $4.5M$5.1M$4.2M$4.7M$5.8M$5.3M$3.3M$2.7M$1.8M$1.7M
Investing cash flow -$60.4M-$45.9M$67.6M-$137.3M-$194.7M-$223.7M-$258.2M-$151.6M-$252.7M-$150.4M
Financing cash flow -$10.3M-$21.9M-$143.8M$62.4M$127.7M$192.7M$224.1M$124.5M$226.6M$163.5M
Dividends paid $5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$745.0K$0
Buybacks $6.0M—————————

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-040956.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -10M 0 10M 20M 30M Revenue, FY2016: 131K Net income, FY2016: -6.4M Revenue, FY2017: 121K Net income, FY2017: -87K Revenue, FY2018: 54K Net income, FY2018: 14.6M Revenue, FY2019: 211K Net income, FY2019: 9.6M Revenue, FY2020: 212K Net income, FY2020: -2.5M Revenue, FY2021: 132K Net income, FY2021: 18.3M Revenue, FY2022: 116K Net income, FY2022: 20M Revenue, FY2023: 115K Net income, FY2023: 21.7M Revenue, FY2024: 370K Net income, FY2024: 6.7M Revenue, FY2025: 526K Net income, FY2025: -6.9M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $131.0K $121.0K $54.0K $211.0K $212.0K $132.0K $116.0K $115.0K $370.0K $526.0K
Gross profit — — — — — — — — — —
Net income -$6.4M -$87.0K $14.6M $9.6M -$2.5M $18.3M $20.0M $21.7M $6.7M -$6.9M

Recent filings and events

  • Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Acquisition or disposal completed Item 2.01
  • Material agreement signed Item 1.01
  • Acquisition or disposal completed Item 2.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6798

TickerCompanyMarket capP/ERevenue growth
WELL WELLTOWER INC. $167.53B 170.7x 40.2%
PLD Prologis, Inc. $117.89B 35.5x 7.2%
EQIX EQUINIX INC $94.23B 69.4x 5.4%
AMT AMERICAN TOWER CORP /MA/ $88.04B 35.0x 20.8%
SPG SIMON PROPERTY GROUP INC. $68.57B 14.9x 6.7%
DLR DIGITAL REALTY TRUST, INC. $60.57B 48.1x 10.0%
PSA Public Storage $54.42B 34.4x 2.7%
O REALTY INCOME CORP $53.83B 48.6x 9.1%